China's strategic push to boost innovation in the pharmaceutical sector is paying off big time! 🌟 Global healthcare heavyweights are racing to expand their footprints in the country, thanks to policies that prioritize cutting-edge research and streamlined regulations. CGTN’s Zhu Zhu recently explored the buzzing Beijing Economic-Technological Development Area, where labs and factories hum with collaboration between international pharma leaders and local talent.
🔬 One exec at a top European drugmaker told reporters: 'China’s focus on developing new medicines and digital health tools makes it a goldmine for innovation.' The area has become a hotspot for R&D, with companies investing millions in AI-driven drug discovery and vaccine production facilities.
💼 Analysts say this boom isn't just about profits—it’s creating jobs, accelerating tech transfers, and positioning China as a global healthcare partner. With over 15% growth in biotech exports last year alone, the momentum shows no signs of slowing. 🚀
